AI-Enabled Real-World Evidence in Oncology: A Statistical Perspective for Regulatory Decisions
Therapeutic Innovation & Regulatory Science · 2026-11 · 60 (6) · 1627-1636
DOI: 10.1007/s43441-026-01036-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 26.08.2026. Verfasst von Lei Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Moderna Inc., Cambridge, MA, USA. lei.gao@modernatx.com. Hauptthemen laut MEDLINE: Artificial Intelligence, Medical Oncology. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Moderna Inc., Cambridge, MA, USA. lei.gao@modernatx.com.
- AbbVie Inc., North Chicago, IL, USA.
- AstraZeneca, Gaithersburg, MD, USA.
Zitieren
APA
Gao, L., Feng, D., & Yu, B. (2026). AI-Enabled Real-World Evidence in Oncology: A Statistical Perspective for Regulatory Decisions. Therapeutic Innovation & Regulatory Science, 60(6), 1627-1636. https://doi.org/10.1007/s43441-026-01036-5
Vancouver
Gao L, Feng D, Yu B. AI-Enabled Real-World Evidence in Oncology: A Statistical Perspective for Regulatory Decisions. Therapeutic Innovation & Regulatory Science. 2026;60(6):1627-1636. doi:10.1007/s43441-026-01036-5
BibTeX
@article{Gao2026,
author = {Gao, Lei and Feng, Dai and Yu, Binbing},
title = {AI-Enabled Real-World Evidence in Oncology: A Statistical Perspective for Regulatory Decisions},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2026},
volume = {60},
number = {6},
pages = {1627--1636},
doi = {10.1007/s43441-026-01036-5}
}
EUVIMED